Life Tech’s Mass-Spec Revenue Falls 12 Percent in Q2; Total Receipts Rise 2 Percent
July 30, 2009
Life Tech’s Mass-Spec Revenue Falls 12 Percent in Q2; Total Receipts Rise 2 Percent
Including the effects of currency exchange, the mass spec business fell 15 percent year over year — the steepest decline among the company’s four divisions.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Expanded Proximity Ligation Assay Could Prove Valuable for Biomarker Studies, Top-Down Proteomics
May 13, 2011 / ProteoMonitor - Life Tech Sues AB Sciex for Improper Use of 'AB' Marks
January 19, 2011 / GenomeWeb Daily News - Movers & Shakers
January 7, 2011 / ProteoMonitor - Life Technologies Launches Benchtop Sample Prep System for Proteomics, Epigenetics
April 30, 2010 / ProteoMonitor - Thermo Fisher 'Ruthlessly' Focused on Winning in Mass-Spec Space, CEO Tells Investors
January 15, 2010 / ProteoMonitor